Hawaii Revised Statutes
329. Uniform Controlled Substances Act
329-22 Schedule V.

§329-22 Schedule V. (a) The controlled substances listed in this section are included in schedule V.
(b) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, which also contains one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone:
(1) Not more than 200 milligrams of codeine, or any of its salts, per 100 milliliters or per 100 grams;
(2) Not more than 100 milligrams of dihydrocodeine, or any of its salts, per 100 milliliters or per 100 grams;
(3) Not more than 100 milligrams of ethylmorphine, or any of its salts, per 100 milliliters or per 100 grams;
(4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;
(5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams; and
(6) Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.
(c) Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers.
(d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers:
(1) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide], (Vimpat);
(2) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid]; and
(3) Brivaracetam ((2S)-2[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts. [L 1972, c 10, pt of §1; am L 1978, c 68, §6; am L 1985, c 150, §4; am L 2003, c 151, §6; am L 2008, c 119, §6; am L 2010, c 123, §4; am L 2017, c 155, §3; am L 2019, c 95, §1; am L 2021, c 233, §4]

Structure Hawaii Revised Statutes

Hawaii Revised Statutes

Title 19. Health

329. Uniform Controlled Substances Act

329-1 Definitions.

329-2 Hawaii advisory commission on drug abuse and controlled substances; number; appointment.

329-3 Annual report.

329-4 Duties of the Hawaii advisory commission on drug abuse and controlled substances.

329-11 Authority to schedule controlled substances.

329-12 Nomenclature.

329-13 Schedule I tests.

329-14 Schedule I.

329-15 Schedule II tests.

329-16 Schedule II.

329-17 Schedule III tests.

329-18 Schedule III.

329-19 Schedule IV tests.

329-20 Schedule IV.

329-21 Schedule V tests.

329-22 Schedule V.

329-23 Republishing and distribution of schedules.

329-31 Rules.

329-31.5 Clinics.

329-32 Registration requirements.

329-33 Registration.

329-34 Revocation and suspension of registration.

329-35 Order to show cause.

329-36 Records of registrants.

329-37 Filing requirements.

329-38 Prescriptions.

329-38.2 Prescriptions; additional restrictions.

329-38.5 Opioid therapy; informed consent process; requirement for written policies.

329-39 Labels.

329-39.5 Opioid warning label.

329-40 Methadone treatment programs.

329-41 Prohibited acts B--penalties.

329-42 Prohibited acts C--penalties.

329-43 Penalties under other laws.

329-43.5 Prohibited acts related to drug paraphernalia.

329-43.6 Overdose prevention; limited immunity.

329-44 Notice of conviction to be sent to licensing board, department of commerce and consumer affairs.

329-45 REPEALED.

329-46 Prohibited acts related to visits to more than one practitioner to obtain controlled substance prescriptions.

329-49 Administrative penalties.

329-50 Injunctive relief.

329-51 Powers of enforcement personnel.

329-52 Administrative inspections.

329-53 Injunctions.

329-54 Cooperative arrangements and confidentiality.

329-55 Forfeitures.

329-56 Burden of proof; liabilities.

329-57 Judicial review.

329-58 Education and research.

329-59 Controlled substance registration revolving fund; established.

329-61 Substances subject to reporting.

329-62 Proper identification.

329-63 Person required to keep records and file reports.

329-64 Exceptions.

329-65 Penalty.

329-66 Theft, loss, and discrepancy reports.

329-67 Permit for conduct of business; applications; forms; fees; renewal; violations.

329-68 Protection of records; divulging confidential information prohibited; penalties.

329-69 Subpoena powers.

329-70 Forfeiture.

329-71 Requirements when selling specific chemicals.

329-72 Rules.

329-73 REPEALED.

329-74 Unlawful transport of pseudoephedrine.

329-75 Sales of products, mixtures, or preparations containing pseudoephedrine; reporting requirement for wholesalers.

329-81 to 91 REPEALED.

329-101 Reporting of dispensation of controlled substances; electronic prescription accountability system; requirements; penalty.

329-102 Central repository.

329-103 Designated state agency.

329-104 Confidentiality of information; disclosure of information.

329-121 Definitions.

329-122 Medical use of cannabis; conditions of use.

329-123 Registration requirements; qualifying patients; primary caregivers.

329-123.5 Registration requirements; qualifying out-of-state patient; caregiver of a qualifying out-of-state patient.

329-124 Insurance not applicable.

329-125 Protections afforded to a qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient.

329-125.5 Medical cannabis patient and caregiver protections.

329-125.6 Protections afforded to an owner or qualified employee of a licensed medical cannabis dispensary.

329-126 Protections afforded to a treating physician or advanced practice registered nurse.

329-127 Protection of cannabis and other seized property.

329-128 Fraudulent misrepresentation; penalty.

329-129 Prohibited acts; flammable solvents.

329-130 Authorized sources of medical cannabis.

329-131 Prescription and pharmacy requirements not applicable.